Gengjie Yang

2.4k total citations
21 papers, 814 citations indexed

About

Gengjie Yang is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Gengjie Yang has authored 21 papers receiving a total of 814 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 8 papers in Molecular Biology and 6 papers in Immunology. Recurrent topics in Gengjie Yang's work include Chemokine receptors and signaling (8 papers), Immune Cell Function and Interaction (6 papers) and Cytokine Signaling Pathways and Interactions (6 papers). Gengjie Yang is often cited by papers focused on Chemokine receptors and signaling (8 papers), Immune Cell Function and Interaction (6 papers) and Cytokine Signaling Pathways and Interactions (6 papers). Gengjie Yang collaborates with scholars based in United States, Germany and Sweden. Gengjie Yang's co-authors include Peggy Scherle, Robert Newton, Jordan S. Fridman, Holly K. Koblish, Rui‐Qin Liu, Kris Vaddi, Michael A. Pratta, Andrew P. Combs, Michael Hansbury and Eddy W. Yue and has published in prestigious journals such as Blood, Cancer Research and Clinical Cancer Research.

In The Last Decade

Gengjie Yang

20 papers receiving 792 citations

Peers

Gengjie Yang
Vera Levina United States
Tzu‐Ting Huang Taiwan
Rohan Mendonca United States
Moyez Dharsee Canada
Kimberly A. Luddy United States
Maria Pinzon-Ortiz United States
Bhaswati Sarcar United States
C. Leah B. Kline United States
Robin Hallett Canada
Johanna M. Schafer United States
Vera Levina United States
Gengjie Yang
Citations per year, relative to Gengjie Yang Gengjie Yang (= 1×) peers Vera Levina

Countries citing papers authored by Gengjie Yang

Since Specialization
Citations

This map shows the geographic impact of Gengjie Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gengjie Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gengjie Yang more than expected).

Fields of papers citing papers by Gengjie Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gengjie Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gengjie Yang. The network helps show where Gengjie Yang may publish in the future.

Co-authorship network of co-authors of Gengjie Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Gengjie Yang. A scholar is included among the top collaborators of Gengjie Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gengjie Yang. Gengjie Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Qian, Shiquan, Cheng‐Tsung Lai, Kelly Federowicz, et al.. (2025). Discovery of Fluoroalkenes as Dual Inhibitors of Diacylglycerol Kinases Alpha and Zeta (DGKα/ζ). Journal of Medicinal Chemistry. 68(19). 20789–20813.
2.
Liu, Xuesong, Matthew C. Stubbs, Min Ye, et al.. (2016). Abstract 4702: Combination of BET inhibitor INCB054329 and LSD1 inhibitor INCB059872 is synergistic for the treatment of AML in vitro and in vivo. Cancer Research. 76(14_Supplement). 4702–4702. 6 indexed citations
3.
Koblish, Holly K., Liang-Chuan Wang, Michael Hansbury, et al.. (2015). Abstract C103: The combination of PI3kδ-selective inhibition and immunomodulation shows efficacy in solid tumor models. Molecular Cancer Therapeutics. 14(12_Supplement_2). C103–C103. 5 indexed citations
4.
Wang, Liang‐Chuan S., Holly K. Koblish, Michael Hansbury, et al.. (2015). Pharmacological inactivation of PI3Kδ in the tumor microenvironment enhances efficacy of other immunotherapeutic agents. Journal for ImmunoTherapy of Cancer. 3(S2). 2 indexed citations
5.
Cherney, Robert J., Ruowei Mo, Dayton T. Meyer, et al.. (2012). Benzimidazoles as benzamide replacements within cyclohexane-based CC chemokine receptor 2 (CCR2) antagonists. Bioorganic & Medicinal Chemistry Letters. 22(19). 6181–6184. 4 indexed citations
6.
Carter, Percy H., Matthew E. Voss, Andrew J. Tebben, et al.. (2012). Discovery of an orally-bioavailable CC Chemokine Receptor 2 antagonist derived from an acyclic diaminoalcohol backbone. Bioorganic & Medicinal Chemistry Letters. 22(9). 3311–3316. 7 indexed citations
7.
Liu, Xiangdong, Qian Wang, Gengjie Yang, et al.. (2011). A Novel Kinase Inhibitor, INCB28060, Blocks c-MET–Dependent Signaling, Neoplastic Activities, and Cross-Talk with EGFR and HER-3. Clinical Cancer Research. 17(22). 7127–7138. 190 indexed citations
8.
Cherney, Robert J., Ruowei Mo, Dayton T. Meyer, et al.. (2010). γ-Lactams as glycinamide replacements in cyclohexane-based CC chemokine receptor 2 (CCR2) antagonists. Bioorganic & Medicinal Chemistry Letters. 20(8). 2425–2430. 15 indexed citations
9.
Koblish, Holly K., Michael Hansbury, Kevin Bowman, et al.. (2010). Hydroxyamidine Inhibitors of Indoleamine-2,3-dioxygenase Potently Suppress Systemic Tryptophan Catabolism and the Growth of IDO-Expressing Tumors. Molecular Cancer Therapeutics. 9(2). 489–498. 204 indexed citations
10.
Cherney, Robert J., Ruowei Mo, Dayton T. Meyer, et al.. (2009). Novel sulfone-containing di- and trisubstituted cyclohexanes as potent CC chemokine receptor 2 (CCR2) antagonists. Bioorganic & Medicinal Chemistry Letters. 19(13). 3418–3422. 12 indexed citations
11.
Cherney, Robert J., Ruowei Mo, Gengjie Yang, et al.. (2008). Discovery of trisubstituted cyclohexanes as potent CC chemokine receptor 2 (CCR2) antagonists. Bioorganic & Medicinal Chemistry Letters. 19(3). 597–601. 15 indexed citations
12.
Cherney, Robert J., David J. Nelson, Gengjie Yang, et al.. (2008). Synthesis and evaluation of cis-3,4-disubstituted piperidines as potent CC chemokine receptor 2 (CCR2) antagonists. Bioorganic & Medicinal Chemistry Letters. 18(18). 5063–5065. 19 indexed citations
13.
Cherney, Robert J., Ruowei Mo, Dayton T. Meyer, et al.. (2008). Discovery of Disubstituted Cyclohexanes as a New Class of CC Chemokine Receptor 2 Antagonists. Journal of Medicinal Chemistry. 51(4). 721–724. 39 indexed citations
14.
Carter, Percy H., Robert J. Cherney, Andrew J. Tebben, et al.. (2007). Capped diaminopropionamide–glycine dipeptides are inhibitors of CC chemokine receptor 2 (CCR2). Bioorganic & Medicinal Chemistry Letters. 17(19). 5455–5461. 15 indexed citations
15.
Burns, David, Chunhong He, Yanlong Li, et al.. (2007). Conversion of an MMP-potent scaffold to an MMP-selective HER-2 sheddase inhibitor via scaffold hybridization and subtle P1′ permutations. Bioorganic & Medicinal Chemistry Letters. 18(2). 560–564. 13 indexed citations
16.
Liu, Xiangdong, Jordan S. Fridman, Qian Wang, et al.. (2006). Selective inhibition of ADAM metalloproteases blocks HER-2 extracellular domain (ECD) cleavage and potentiates the anti-tumor effects of trastuzumab. Cancer Biology & Therapy. 5(6). 648–656. 45 indexed citations
17.
Voss, Matthew E., Percy H. Carter, Andrew J. Tebben, et al.. (2003). Both 5-arylidene-2-thioxodihydropyrimidine-4,6(1H,5H)-diones and 3-thioxo-2,3-dihydro-1H-imidazo[1,5-a]indol-1-ones are light-Dependent tumor necrosis factor-α antagonists. Bioorganic & Medicinal Chemistry Letters. 13(3). 533–538. 58 indexed citations
18.
Pratta, Michael A., Peggy Scherle, Gengjie Yang, Rui‐Qin Liu, & Robert Newton. (2003). Induction of aggrecanase 1 (ADAM‐TS4) by interleukin‐1 occurs through activation of constitutively produced protein. Arthritis & Rheumatism. 48(1). 119–133. 82 indexed citations
19.
Zhao, Yi, Yuanguang Lin, Yuxia Zhan, et al.. (2000). Murine hematopoietic stem cell characterization and its regulation in BM transplantation. Blood. 96(9). 3016–3022. 6 indexed citations
20.
Zhao, Yi, Yuanguang Lin, Yuxia Zhan, et al.. (2000). Murine hematopoietic stem cell characterization and its regulation in BM transplantation. Blood. 96(9). 3016–3022. 69 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Vera Levina Breakdown of academic impact, for papers by Tzu‐Ting Huang Breakdown of academic impact, for papers by Rohan Mendonca Breakdown of academic impact, for papers by Moyez Dharsee Breakdown of academic impact, for papers by Kimberly A. Luddy Breakdown of academic impact, for papers by Maria Pinzon-Ortiz Breakdown of academic impact, for papers by Bhaswati Sarcar Breakdown of academic impact, for papers by C. Leah B. Kline Breakdown of academic impact, for papers by Robin Hallett Breakdown of academic impact, for papers by Johanna M. Schafer
Rankless by CCL
2026